HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gimenez, A. P. Articles by Goossens, P. L. Search for Related Content PubMed PubMed Citation Articles by Gimenez, A. P. Articles by Goossens, P. L.

High Bactericidal Efficiency of Type IIA Phospholipase A₂ against Bacillus anthracis and Inhibition of Its Secretion by the Lethal Toxin¹

Alejandro Piris Gimenez^*, Yong-Zheng Wu, Miguel Paya, Christophe Delclaux, Lhousseine Touqui and Pierre L. Goossens^2,*

^* Unité Toxines et Pathogénie Bactérienne/Centre National de la Recherche Scientifique, and Unité de Défense Innée et Inflammation/Unité Associée, Institut National de la Santé et de la Recherche Médicale, Institut Pasteur, Paris, France; and Institut National de la Santé et de la Recherche Médicale, Unité 492, Service de Physiologie-Explorations Fonctionnelles, Hôpital Henri Mondor, Créteil, France

There is a considerable body of evidence supporting the role of secretory type II-A phospholipase A₂ (sPLA₂-IIA) as an effector of the innate immune response. This enzyme also exhibits bactericidal activity especially toward Gram-positive bacteria. In this study we examined the ability of sPLA₂-IIA to kill Bacillus anthracis, the etiological agent of anthrax. Our results show that both germinated B. anthracis spores and encapsulated bacilli were sensitive to the bactericidal activity of recombinant sPLA₂-IIA in vitro. In contrast, nongerminated spores were resistant. This bactericidal effect was correlated to the ability of sPLA₂-IIA to hydrolyze bacterial membrane phospholipids. Guinea pig alveolar macrophages, the major source of sPLA₂-IIA in an experimental model of acute lung injury, released enough sPLA₂-IIA to kill extracellular B. anthracis. The production of sPLA₂-IIA was significantly inhibited by B. anthracis lethal toxin. Human bronchoalveolar lavage fluids from acute respiratory distress syndrome patients are known to contain sPLA₂-IIA; bactericidal activity against B. anthracis was detected in a high percentage of these samples. This anthracidal activity was correlated to the levels of sPLA₂-IIA and was abolished by an sPLA₂-IIA inhibitor. These results suggest that sPLA₂-IIA may play a role in innate host defense against B. anthracis infection and that lethal toxin may help the bacteria to escape from the bactericidal action of sPLA₂-IIA by inhibiting the production of this enzyme.

This article has been cited by other articles:

				Y. P. Gauthier, J.-N. Tournier, J.-C. Paucod, J.-P. Corre, M. Mock, P. L. Goossens, and D. R. Vidal Efficacy of a Vaccine Based on Protective Antigen and Killed Spores against Experimental Inhalational Anthrax Infect. Immun., March 1, 2009; 77(3): 1197 - 1207. [Abstract] [Full Text] [PDF]

				B. P. Hurley and B. A. McCormick Multiple Roles of Phospholipase A2 during Lung Infection and Inflammation Infect. Immun., June 1, 2008; 76(6): 2259 - 2272. [Full Text] [PDF]

				W. van Schaik, J. Prigent, and A. Fouet The stringent response of Bacillus anthracis contributes to sporulation but not to virulence Microbiology, December 1, 2007; 153(12): 4234 - 4239. [Abstract] [Full Text] [PDF]

				I. J. Glomski, J.-P. Corre, M. Mock, and P. L. Goossens Cutting Edge: IFN-{gamma}-Producing CD4 T Lymphocytes Mediate Spore-Induced Immunity to Capsulated Bacillus anthracis J. Immunol., March 1, 2007; 178(5): 2646 - 2650. [Abstract] [Full Text] [PDF]

				W. J. Ribot, R. G. Panchal, K. C. Brittingham, G. Ruthel, T. A. Kenny, D. Lane, B. Curry, T. A. Hoover, A. M. Friedlander, and S. Bavari Anthrax Lethal Toxin Impairs Innate Immune Functions of Alveolar Macrophages and Facilitates Bacillus anthracis Survival Infect. Immun., September 1, 2006; 74(9): 5029 - 5034. [Abstract] [Full Text] [PDF]

				B. Grubor, D. K. Meyerholz, and M. R. Ackermann Collectins and cationic antimicrobial peptides of the respiratory epithelia. Vet. Pathol., September 1, 2006; 43(5): 595 - 612. [Abstract] [Full Text] [PDF]

				J. A. Tree, M. J. Elmore, S. Javed, A. Williams, and P. D. Marsh Development of a Guinea Pig Immune Response-Related Microarray and Its Use To Define the Host Response following Mycobacterium bovis BCG Vaccination Infect. Immun., February 1, 2006; 74(2): 1436 - 1441. [Abstract] [Full Text] [PDF]

				T. Candela, M. Mock, and A. Fouet CapE, a 47-Amino-Acid Peptide, Is Necessary for Bacillus anthracis Polyglutamate Capsule Synthesis J. Bacteriol., November 15, 2005; 187(22): 7765 - 7772. [Abstract] [Full Text] [PDF]

				A. Piris-Gimenez, M. Paya, G. Lambeau, M. Chignard, M. Mock, L. Touqui, and P. L. Goossens In Vivo Protective Role of Human Group IIA Phospholipase A2 against Experimental Anthrax J. Immunol., November 15, 2005; 175(10): 6786 - 6791. [Abstract] [Full Text] [PDF]